Recent News
January 3, 2012 PathSensors, Inc. Introduces the
BioFlash-AF® Biological Identifier at The IPE® 2012PathSensors, Inc. introduces the BioFlash-AF® Biological Identifier, a rugged, portable, high-performance aerosol sampler for testing and detection of pathogens. Incorporating the CANARY® technology, the BioFlash-AF® provides rapid, sensitive and specific identification of bacterial and viral agents from aerosol samples. The portable and compact BioFlash-AF® offers breakthrough capabilities in sampling performance, reliability and operational cost. (more)
December 16, 2011 PathSensors selected as one of five promising life sciences companies to receive Biotechnology Commercialization Award of $200,000.
The Baltimore-based company located in the University of Maryland BioPark, will use the State funds to extend its biosensor product line to include Campylobacter detection.
In effort to spur commercialization and advance treatments for cancer and other diseases, the Maryland Biotechnology Center (MBC) today announced it has awarded a total of $1 million to five promising life sciences companies through its Biotechnology Commercialization Awards and Translational Research awards. The companies, which received up to $200,000 each, will use the funding to advance cancer therapies, ensure food safety, more quickly detect infectious disease and develop more efficient cardiac repair. (more)
July 14, 2011 PathSensors Delivering New Wave of Biodefense
PathSensors, Inc., an environmental testing company housed at the University of Maryland Biopark in Baltimore, has taken its biodefense technology to a new level. The company specializes in developing tests to quickly find pathogens in the infectious disease and biodefense sectors.
Currently, the company has the only product in the market that can detect 21 biological threat agents in three minutes – no other product can detect at that speed. On top of its speedy performance, it is portable, easily operated, and low maintenance. (more)
July 3, 2011 Maryland takes advantage of biotech convention’s proximity
Maryland erected one of the more eye-catching displays at last week’s Biotechnology Industry Organization convention, rolling out a large swath of plush, white carpet under 30 exhibit booths, a small cafe, multiple seating areas and a product showcase.
The setup, which sat adjacent to a well-trafficked exhibit hall entrance, sent a targeted message to attendees: Maryland is a biotechnology anchor, and it’s not to be missed. (more)May 18, 2011 (National) Anthrax attack threat persists, DHS says.
The U.S. government must remain poised to deal with another attack involving anthrax, a senior DHS official warned the week of May 9. "The threat of an attack using a biological agent is real and requires that we remain vigilant. A wide-area attack using aerosolized Bacillus anthracis, the bacteria that causes anthrax, is one of the most serious mass casualty biological threats facing the U.S.," the DHS chief medical officer said during a May 12 hearing of the House Homeland Security emergency preparedness subcommittee. (more)
January 14, 2011 Evergreen Advisors Helps PathSensors, Inc Restructure in Baltimore
Washington, DC/Baltimore, MD — Evergreen Advisors' client PathSensors, Inc., an environmental testing company that manufactures pathogen identification systems is positioning itself for future growth. Recently spun-off from Rockville based Innovative Biosensors Inc. (IBI), Pathsensors is a leading edge biotech company focused on the food testing and biosecurity market. The company recently was awarded a $5 million contract from the Department of Defense. (more)
January 5, 2011 Montgomery biotech breaks away from parent, lands in Baltimore. PathSensors, with $5M DoD contract, ready to grow
An environmental testing biotech has broken away from its Rockville parent and is charting its own course at the University of Maryland BioPark in Baltimore. PathSensors, which manufactures pathogen identification systems and their study kits, split in November from Innovative Biosensors. Innovative, formed in 2004, uses technology from the Massachusetts Institute of Technology to detect pathogens in clinical applications. (more)
